Latent Tuberculosis Infection: Clinical Trials

1 trial for Latent Tuberculosis Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Latent Tuberculosis Infection: new trials by email Literature Review of Latent Tuberculosis Infection trials Research Report on Latent Tuberculosis Infection

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTIĀ® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis Infection
RUTI, RUTI Matching Placebo - Latent Tuberculosis Infection, Tuberculosis
Phase 2CompletedArchivel Farma S.L.952010-06-012013-01-24

Narrower conditions

Latent Tuberculosis (1)  ·  Tuberculosis (1)

Broader conditions

Actinomycetales Infections (1)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Infections (1)  ·  Latent Infection (1)  ·  Mycobacterium Infections (1)

Sponsors

Archivel Farma S.L. (1)

Countries

South Africa (1)

Top investigators

Pere Joan Cardona, MD, PhD (1)

Results publications

PMID 24586912